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1. Introduction 
Pyruvate dehydrogenase complex (PDH complex) 
(EC 1.2.4.1) occupies a key position in metabolism 
between glycolysis and several important metabolic 
pathways. Consequently, the following regulatory 
properties of the multienzyme complex have been 
extensively investigated [l] : (1) product inhibition 
by acetyl CoA or NADH which is reversed by CoA or 
NAD’, (2) feedback regulation by nucleotides, and 
(3) regulation by covalent modification; inactivation 
by phosphorylation and reactivation by dephosphory- 
lation. In addition, Wieland [2] has reported inactiva- 
tion of PDH complex in rat liver mediated by a proteo- 
lytic enzyme(s) localized in mitochondrial lysosomes. 
This inactivation appears to be resulted from disaggre- 
gation of the multienzyme complex by limited proteo- 
lysis. 
The present communication deals with the presence 
in Streptococcus fuecalis of a thermostable inhibitor(s) 
which affects the overall activity of the multienzyme 
complex. 
2. Materials and methods 
2.1. Organisms 
S. faecalis lOC1 (ATCC 11700) and its mutant, 
H-1-12, isolated as described previously [3] were culti- 
vated in a synthetic medium [4] with supplement of 
2 mM sodium acetate. 
2.2. Cell-free extracts 
Cells collected at the end of logarithmic phase of 
62 
growth were treated with lysozyme prior to a brief 
sonication [4] to minimize inactivation of PDH com- 
plex during sonication. The homogenate was centrifuged 
at IO 000 X g for 40 min. The resulting supernatant 
was divided into two portions. One was activated with 
DLlipoic acid as described by Leach et al. [5] and then 
dialyzed against three changes of 0.02 M potassium 
phosphate buffer (pH 7.0) at 4°C for 20-24 h with 
agitation. The lipoic acid-treated extracts are referred 
to as ‘activated’ extracts, in which PDH complex would 
exist in the form of holoenzyme. The other portion of 
the supernatant was incubated and dialyzed in the 
same way as in preparing the ‘activated’ extracts except 
that lipoic acid was not added. PDH complex in the 
lipoic acid-free extracts would contain the dihydro- 
lipoyl transacetylase component in the form of apo- 
enzyme. 
2.3. Enzyme assays 
PDH complex activity was routinely measured 
according to the method of Leach et al. [5]. The 
activities of the component enzymes of the complex 
were assayed by the methods of Reed et al. [6] 
with the following modifications; (1) for the assay of 
dihydrolipoyl transacetylase (EC 2.3.1.12), potassium 
phosphate buffer was used in place of Tris buffer, (2) 
the reaction of dihydrolipoamide dehydrogenase 
(EC 1.6.4.3) was followed under anaerobic conditions 
to eliminate the influence of NADH oxidation. 
2.4. Assay of inhibitor(s) 
The lipoic acid-free extracts obtained as described 
above were boiled for 5 min and the precipitates form- 
ed were removed by centrifugation. The resulting super- 
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natant was dialyzed as above and used as the inhibitor 
preparation. The activity of inhibitor(s) was determined 
by measuring the decrease in the activity of PDH 
complex. One unit of the inhibitor(s) is defined as the 
amount which causes the reduction of 1 nmol acetyl 
phosphate formation from pyruvate under the above 
conditions. 
2.5. Gel-filtration of inhibitor(s) 
The boiled extracts described above were treated 
with streptomycin to remove nucleic acids before 
dialysis. The dialyzed extracts were concentrated in 
an Amicon (Lexington, Mass. USA) ultrafiltration cell 
with a UM2 membrane at a constant pressure of 
nitrogen gas. The preparations obtained were chromato- 
graphed on a column of Bio-gel A-O.5 m (1.6 X 60 cm) 
equilibrated with 20 mM Tris buffer (pH 7.4) con- 
taining 1 mM EDTA and 0.1 M NaCI. The column was 
eluted with the same buffer and fractions of 1 ml were 
collected. The inhibitor activity of these fractions was 
assayed as described above. For the determination of 
the molecular weight of the inhibitor, yeast alcohol 
dehydrogenase (mol. wt. 148 000) bovine pancreas 
a-chymotripsinogen A (mol. wt 23 650) and bovine 
pancreas ribonuclease A (mol. wt 14 000) were used to 
calibrate the column. 
2.6. Protein determination 
The concentrations of protein in the extracts were 
estimated according to the method of Lowry et al. [7]. 
2.7. Chemicals 
Dihydrolipoamide was prepared from DL-lipoamide 
according to the method of Reed et al. [8]. All 
chemicals used were analytical grade. 
3. Results and discussion 
3.1. i%e presence of a thermostable inhibitor(s) of 
PDH complex 
As illustrated in fig.1 A, the activity of PDH complex 
in cell-free extracts from S. faecalis 1OCl was propor- 
tional to the concentration of protein up to a range of 
4-5 mg/ml when the extracts were activated previously 
with lipoic acid as described in Materials and methods. 
However, the enzyme activity decreased markedly upon 
addition of the lipoic acid-free extracts. The results 
strongly suggest he existence of an inhibitory factor(s) 
of PDH complex in the extracts. 
As described below, the inhibitory factor(s) was 
observed to be a thermostable protein(s) and shown to 
exist also in the ‘activated’ extracts. However, the 
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Fig.1. Inhibitory effect of lipoic acid-free extracts from S. fuecalis on the activity of pyruvate dehydrogenase complex. Open 
circles refer to the activity of the enzyme as a function of protein concentration (A: parental, B and C: mutant H-l-l 2). Closed 
circles indicate change in the enzyme activity upon addition of the lipoic acid-free extracts (A: parental, B: H-1-12, C: H-l-l 2 
(boiled)). Preparation of the cell-free extracts and assay of PDH complex were carried out as described in Materials and methods. 
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inhibitory effect was not observed in the extracts, 
presumably due to the higher activity of PDH complex 
than that of the inhibitor(s). 
It seems to be probable that the inhibition of 
PDH complex may occur through that of either lactate 
dehydrogenase (EC 1 .l .1.27) or phosphotransacetylase 
(EC 2.3.1.8) participating in the dismutation reaction 
of pyruvate. This possibility could be ruled out since 
the ratios of these enzymes to the inhibitor(s) in the 
lipoic acid-free extracts would be the same as those in 
the ‘activated’ ones. NADH as well as acetyl CoA is 
not involved in the inhibitory action of the cell-free 
extracts since the extracts were exhaustively dialyzed 
before use. For the same reason, phosphorylation of 
PDH complex can be ruled out. 
As described previously [3], S. fuecalis possesses 
three separate enzyme systems for pyruvate dehydro- 
genation, namely PDH complex, pyruvate formate- 
lyase and an unidentified enzyme system. Although the 
enzyme activities can be estimated independently 
from each other [3], preliminary experiments revealed 
that the level of PDH complex was affected by the 
occurrence of the two other enzyme systems (data to 
be published elsewhere). Hence, a mutant, H-1-12, 
having only PDH complex for pyruvate dehydrogena- 
tion, was employed for further investigation. The 
activity of PDH complex in this mutant was also inhi- 
bited by the addition of lipoic acid-free extracts from 
its own cells as shown in fig.1 B. It would be, therefore, 
concluded that similar inhibitory factor(s) to that in 
the parental strain was present in the mutant. Figure 1 C 
shows that the inhibitory factor(s) was thermostable. 
Boiling of the lipoic acid-free extracts did not affect the 
inhibitory effect on the activity of PDH complex. The 
inhibition of PDH complex occurred upon addition of 
boiled extracts from the parental strain to the ‘activat- 
ed’ extracts from H-l - 12, or vice versa, indicating 
further the similarity of the inhibitor(s) from both 
strains. The presence of the inhibitor activity was 
detected also in the ‘activated’ extracts by boiling 
them before use. 
3.2. The properties of the inhibitor(s)ofPDHcomplex 
The activity of the inhibitor(s) was reduced by 
treatment with a low concentration of trypsin (tig.2). 
The inhibitory activity was acid-stable, since it was 
able to be recovered without loss after trichloroacetic 
acid (3%) treatment. 
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Fig.2. Effect of trypsin on the inhibitor(s) of pyruvate dehydro- 
genase complex. Boiled extracts (0.78 mg protein) from 
H-1-12 cells were incubated with bovine pancreatic trypsin at 
a ratio of 5: 1 by weight. At indicated times, tryptic digestion 
was terminated by the addition of a 4-fold excess by weight of 
soybean trypsin inhibitor. The inhibitor activity of PDH 
complex was then determined. Open circles refer to residual 
activity of the inhibitor(s) after treatment with trypsin. Closed 
circles indicate activity of PDH complex after incubation with 
the trypsin-treated inhibitor(s). The enzyme activity.in the 
absence of inhibitor(s) was taken as 100%. 
The behavior of the inhibitor preparation on a Bio- 
gel 0.5 m agarose column is shown in fig.3. Two 
distinct peaks of inhibitory activity were observed, 
although the inhibitor in fraction 86-95 should be the 
major component. This main inhibitor was found to 
have a molecular weight of 17 000 as determined by 
the column chromatography on Bio-gel A-O.5 m. 
These results strongly suggest hat the inhibitor(s) of 
PDH complex found in S. faecaZis is a thermostable 
protein(s). 
As shown in fig.4 and 5, the three component 
enzymes of PDH complex exhibited no loss in activity 
when examined individually with the lipoic acid-free 
extracts. This would mean that the inhibitor(s) causes 
a certain disaggregation of the multienzyme complex 
as found for the inactivation of PDH complex by 
extracts from rat mitochondria [2] and for the inacti- 
vation of 2-oxoglutarate dehydrogenase complex by 
extracts from bovine kidney mitochondria [9]. How- 
Volume 74, number 1 FEBS LETTERS February 1977 
40 
F rat tion ‘hmber 
60 
Fig.3. Bio-gel A-O.5 m chromatography of the inhibitor preparation. Boiled extracts from H-1-12 cells were treated with streptomycin 
and concentrated as described in Materials and methods. The inhibitor preparation (0.8 ml) was applied to a column of Bio-gel 
A-O.5 m (1.6 X 60 cm) equilibrated with 20 mM Tris buffer (pH 7.4) containing 1 mM EDTA and 0.1 M NaCl. One-milliliter frac- 
tions were collected. The column was monitored for absorbance at 280 nm (open circles) and for inhibitor activity (closed circles). 
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Fig.4. Effect of boiled extracts from H-1-12 cells on the activities of pyruvate dehydrogenase (A) and dihydrolipoyl transacetylase 
(B). In each case, open circles represent change in the enzyme activity as a function of the amount of boiled extracts added. The 
change in the activity of PDH complex under the same conditions is also represented as control (closed circles). The enzymes were 
assayed as described in Materials and methods. 
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Fig.5. Effect of boiled extracts from H-1-12 cells on the time 
course reaction of dihydrolipoamide dehydrogenase. Arrows A 
and B represent he addition of the substrate, DL-lipoamide 
and that of the boiled extracts (8.8 mg protein), respectively. 
The amount of the boiled extracts was enough to inhibit the 
activity of PDH complex. The enzyme activity was determined 
as described in Materials and methods. 
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ever, the enzyme inactivation reported in this literature 
has been considered caused by limited proteolysis and 
hence the mechanism would be quite different from 
the PDH complex inhibition in S. faecalis. 
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